Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay

938.57 - 962.154 Dr. Rana McKay

But when I am using an ARSI, I think it just gets very complicated for the patients to also have to worry about getting their first generation antiandrogen while we're getting their Abby on board or Enza on board. You know, we may just tell them to start their Abby or Enza first and then come in later for the injection. So at the end of the day, do I think that that impacts overall survival? No.